These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15351389)

  • 1. Designed calix[8]arene-based ligands for selective tryptase surface recognition.
    Mecca T; Consoli GM; Geraci C; Cunsolo F
    Bioorg Med Chem; 2004 Oct; 12(19):5057-62. PubMed ID: 15351389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological activity of a targeted library of potential tryptase inhibitors.
    García M; del Rio X; Silvestre S; Rubiralta M; Lozoya E; Segarra V; Fernández D; Miralpeix M; Aparici M; Diez A
    Org Biomol Chem; 2004 Jun; 2(11):1633-42. PubMed ID: 15162216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
    Scarpi D; McBride JD; Leatherbarrow RJ
    Bioorg Med Chem; 2004 Dec; 12(23):6045-52. PubMed ID: 15519150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Yersinia protein tyrosine phosphatase by phosphonate derivatives of calixarenes.
    Vovk AI; Kononets LA; Tanchuk VY; Cherenok SO; Drapailo AB; Kalchenko VI; Kukhar VP
    Bioorg Med Chem Lett; 2010 Jan; 20(2):483-7. PubMed ID: 20015646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
    Sutton JC; Bolton SA; Davis ME; Hartl KS; Jacobson B; Mathur A; Ogletree ML; Slusarchyk WA; Zahler R; Seiler SM; Bisacchi GS
    Bioorg Med Chem Lett; 2004 May; 14(9):2233-9. PubMed ID: 15081015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure.
    Selwood T; McCaslin DR; Schechter NM
    Biochemistry; 1998 Sep; 37(38):13174-83. PubMed ID: 9748324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.
    Pereira PJ; Bergner A; Macedo-Ribeiro S; Huber R; Matschiner G; Fritz H; Sommerhoff CP; Bode W
    Nature; 1998 Mar; 392(6673):306-11. PubMed ID: 9521329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient synthesis of an enantiopure beta-lactam as an advanced precursor of thrombin and tryptase inhibitors.
    Annunziata R; Benaglia M; Cinquini M; Cozzi F; Maggioni F; Puglisi A
    J Org Chem; 2003 Apr; 68(7):2952-5. PubMed ID: 12662075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial approaches towards the discovery of new tryptase inhibitors.
    del Fresno M; Fernández-Forner D; Miralpeix M; Segarra V; Ryder H; Royo M; Albericio F
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1659-64. PubMed ID: 15745817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach to inhibit human β-tryptase by protein surface binding of four-armed peptide ligands with two different sets of arms.
    Jiang QQ; Bartsch L; Sicking W; Wich PR; Heider D; Hoffmann D; Schmuck C
    Org Biomol Chem; 2013 Feb; 11(10):1631-9. PubMed ID: 23358683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of active monomers from tetrameric human beta-tryptase.
    Fajardo I; Pejler G
    Biochem J; 2003 Feb; 369(Pt 3):603-10. PubMed ID: 12387726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of bivalent ligands using hydrogen bond linkers: synthesis and evaluation of inhibitors for human beta-tryptase.
    Vaz RJ; Gao Z; Pribish J; Chen X; Levell J; Davis L; Albert E; Brollo M; Ugolini A; Cramer DM; Cairns J; Sides K; Liu F; Kwong J; Kang J; Rebello S; Elliot M; Lim H; Chellaraj V; Singleton RW; Li Y
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6053-6. PubMed ID: 15546728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of human tryptase-beta with small molecule inhibitors provides new insights into the unusual functional instability and quaternary structure of the protease.
    Selwood T; Smolensky H; McCaslin DR; Schechter NM
    Biochemistry; 2005 Mar; 44(9):3580-90. PubMed ID: 15736967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-guided design of peptide-based tryptase inhibitors.
    McGrath ME; Sprengeler PA; Hirschbein B; Somoza JR; Lehoux I; Janc JW; Gjerstad E; Graupe M; Estiarte A; Venkataramani C; Liu Y; Yee R; Ho JD; Green MJ; Lee CS; Liu L; Tai V; Spencer J; Sperandio D; Katz BA
    Biochemistry; 2006 May; 45(19):5964-73. PubMed ID: 16681368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor.
    Selwood T; Elrod KC; Schechter NM
    Biol Chem; 2003 Dec; 384(12):1605-11. PubMed ID: 14719803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and thermodynamic analysis of leech-derived tryptase inhibitor interaction with bovine tryptase and bovine trypsin.
    Erba F; Fiorucci L; Sommerhoff CP; Coletta M; Ascoli F
    Biol Chem; 2000 Nov; 381(11):1117-22. PubMed ID: 11154069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
    Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE
    J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.
    Rice KD; Gangloff AR; Kuo EY; Dener JM; Wang VR; Lum R; Newcomb WS; Havel C; Putnam D; Cregar L; Wong M; Warne RL
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2357-60. PubMed ID: 11055355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase.
    Bisacchi GS; Slusarchyk WA; Bolton SA; Hartl KS; Jacobs G; Mathur A; Meng W; Ogletree ML; Pi Z; Sutton JC; Treuner U; Zahler R; Zhao G; Seiler SM
    Bioorg Med Chem Lett; 2004 May; 14(9):2227-31. PubMed ID: 15081014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer based design, synthesis and biological evaluation of novel indole derivatives as HCV NS3-4A serine protease inhibitors.
    Ismail NS; El Dine RS; Hattori M; Takahashi K; Ihara M
    Bioorg Med Chem; 2008 Sep; 16(17):7877-87. PubMed ID: 18752958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.